DeepIntent Creates First of Its Kind Advertising Marketplace

The marketing technology company has launched a Healthcare Marketplace, the first data-rich, and privacy-safe digital environment where healthcare advertisers, publishers, and data providers can collaborate.

“The industry is moving towards first-party data, direct inventory, and rigorous privacy regulation, signaling big changes to the way healthcare marketing operates,” DeepIntent CEO, Chris Paquette, explained in a statement. “Our Healthcare Marketplace lets buyers [advertisers] and sellers [publishers] integrate and collaborate on campaigns directly within a privacy-safe environment. It’s a superior and sustainable solution that improves campaign performance while enabling the economics healthcare publishers need.”

Publisher’s benefit from DeepIntent’s network of 200+ healthcare brands, bringing them data and demand that help engage their healthcare professional user-base with relevant advertising. Healthcare advertisers can trade directly with publishers and buy across the open exchange. The platform does not allow movement of audience data, segments, and real-time bidding (RTB) ad requests outside its platform, assuring data privacy.

Learn more about our Healthcare Marketplace here

More News

Connected TV works ‘harder and smarter’ for the ad dollar, new analysis finds
As more and more people flock to streaming channels over traditional TV, pharma ad dollars are following them. In this article for Fierce Pharma,...
Read More
Hands typing on laptop with a line graph on screen
Tapping new tech helps marketers matchmake rare disease drugs for elusive patients
Treating rare diseases is challenging enough, so you can imagine how difficult it is to reach the right healthcare audiences with info about specialty...
Read More
2022 image
Pharma marketing 2022: More digital shifts for reps, ads and drug launches, plus reputation and the metaverse
What trends can healthcare marketers expect in 2022? In this article for Endpoints News, CEO Chris Paquette discusses how pharma brands will be increasing...
Read More